CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...